Blood News and Research

RSS

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Medco Health Solutions, Inc.(NYSE: MHS) and the American Medical Association (AMA) today announced the findings of a national benchmark survey on physicians' acceptance, use and education regarding pharmacogenomic testing.

23 Oct 2009

Guidance for Quick-Med Technologies’ NIMBUS barrier gauze wound dressings issued

Quick-Med Technologies, Inc. announced today that the Food and Drug Administration has issued Guidance to support the classification of the Company’s NIMBUS® barrier gauze wound dressings as Class II medical devices.

23 Oct 2009

Modified NAGA: New enzyme for enzyme replacement therapy

A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.

23 Oct 2009

Follow healthy lifestyle to overturn genetic predisposition to heart disease

When it comes to heart disease, lifestyle usually trumps genetics, says noted genetic researcher Dr. Robert Hegele, Heart and Stroke Foundation of Canada Lecturer at the Canadian Cardiovascular Congress 2009.

23 Oct 2009

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Someone healthy enough to work could still cost an employer more than $4,000 annually in unnecessary health care costs.

23 Oct 2009

Shire announces new pharmacokinetic data of ADHD medication

Shire plc, the global specialty biopharmaceutical company, announced new data about the pharmacokinetics of its Attention-Deficit/Hyperactivity Disorder (ADHD) medication, Vyvanse- (lisdexamfetamine dimesylate) Capsules CII, which showed that Vyvanse provided similar concentrations of its active medication in the blood when administered either intranasally or when administered orally.

23 Oct 2009

DDT exposure is associated with urogenital birth defects in newborn boys

Women who lived in villages sprayed with DDT to reduce malaria gave birth to 33 per cent more baby boys with urogenital birth defects (UGBD) between 2004 and 2006 than women in unsprayed villages, according to research published online by the UK-based urology journal BJUI.

23 Oct 2009

Vasamed partners with BBHOP for peripheral arterial disease research

On Saturday, November 7, 2009 Vasamed Inc., provider of diagnostic technologies that detect peripheral arterial disease in patients with diabetes, will partner with the Black Barbershop Health Outreach Program (BBHOP) in its mission to help African Americans identify the connection between peripheral arterial disease (PAD), diabetes, obesity and hypertension through early detection and referral to appropriate medical resources.

23 Oct 2009

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Families of Spinal Muscular Atrophy (FSMA) announced today that it has entered into a groundbreaking exclusive license agreement with Repligen Corporation for the development of a potential treatment of Spinal Muscular Atrophy (SMA).

23 Oct 2009

Invatec receives approval to market Mo.Ma device

Invatec, a comprehensive innovator of interventional products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Mo.Ma® Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS).

23 Oct 2009

Medtronic announces ONSET trial results of sensor-enhanced CSII in children

Medtronic, Inc. today announced study results from an oral presentation at the International Diabetes Federation’s World Diabetes Congress held in Montreal, Canada. This scientific convention highlights the latest developments in clinical research aimed at improving diabetes management and outcomes.

23 Oct 2009

Canadian Cardiovascular Society to honor University of Alberta medical researcher

A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure.

23 Oct 2009

Most health professionals lack access to tests for diagnosing primary syphilis, reveals survey

Although syphilis is one of the oldest known diseases, most health professionals do not have access to the tests necessary to reliably diagnose it in its earliest and most infectious stage. A recent survey of infectious diseases specialists regarding the diagnosis and treatment of syphilis appears in the November 15, 2009 issue of Clinical Infectious Diseases, now available online.

23 Oct 2009

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.

23 Oct 2009

U.N. report documents how opium contributes to spread of disease, deaths

The U.N. Office on Drugs and Crime (UNODC) on Wednesday released a report - "Addiction, Crime and Insurgency: The Transnational Threat of Afghan Opium" - documenting how "[t]he smuggling of Afghan opiates is fueling addiction and drug use along trafficking routes from Iran to Central Asia," and contributing to the spread of diseases, the Associated Press reports (Oleksyn, 10/21).

23 Oct 2009

Non-adherence to medication may be the cause for difficult asthma

Difficult-to-treat asthma often may have more to do with patients who do not take their medication as instructed than ineffective medication, according to researchers in Northern Ireland.

23 Oct 2009

Early diagnostic for ovarian cancer to be developed

BioProspecting NB Inc. (BPNBI) and the Atlantic Cancer Research Institute (ACRI) have established a formal collaboration to develop an early diagnostic for ovarian cancer based on BPNBI's unique, proprietary cancer management platform.

23 Oct 2009

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

ZyGEM Corp. Ltd. and Phthisis Diagnostics today announced that they have entered into an agreement to develop products enabling the detection of infectious pathogens in complex samples, such as stool, blood and water.

23 Oct 2009

Important guidelines from IDF for diabetes care

The Guidelines are the work of the IDF Task Force on Clinical Guidelines, which is focused on meeting the critical global need to provide up-to-date evidence-based information and training for healthcare professionals.

23 Oct 2009

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass grafting (CABG) Surgery.

22 Oct 2009

Blood News and Research

Physicians' recognize benefits of genetic testing; say formal education required to put it into practice

Guidance for Quick-Med Technologies’ NIMBUS barrier gauze wound dressings issued

Modified NAGA: New enzyme for enzyme replacement therapy

Follow healthy lifestyle to overturn genetic predisposition to heart disease

Workers with MetS can cost employers up to $5,867 in health care annually: Study

Shire announces new pharmacokinetic data of ADHD medication

DDT exposure is associated with urogenital birth defects in newborn boys

Vasamed partners with BBHOP for peripheral arterial disease research

Families of Spinal Muscular Atrophy and Repligen partner to develop a treatment for SMA

Invatec receives approval to market Mo.Ma device

Medtronic announces ONSET trial results of sensor-enhanced CSII in children

Canadian Cardiovascular Society to honor University of Alberta medical researcher

Most health professionals lack access to tests for diagnosing primary syphilis, reveals survey

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

U.N. report documents how opium contributes to spread of disease, deaths

Non-adherence to medication may be the cause for difficult asthma

Early diagnostic for ovarian cancer to be developed

ZyGEM and Phthisis Diagnostics to develop products for detecting infectious pathogens

Important guidelines from IDF for diabetes care

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News